Medtech Matters

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we look at ways in which medical device manufacturers can benefit from a commercial strategy standpoint through the leveraging of its regulatory strategy. Knowing how to make the regulatory process more challenging to help prevent “me too” products to reach the market can be a commercial advantage for medtech firms. Specifically, the following questions are addressed:First, why don’t we begin with you describing exactly what you mean when you say a company’s regulatory strategy? And is that strategy company-wide or does a regulatory strategy change with each product?Who should be involved with the creation of a regulatory strategy if anyone beyond the regulatory representative?So how does the regulatory strategy and commercial strategy intertwine?What benefits can be realized from this approach?Would you please provide some real world example to further help illustrate the relationship between the two w